Dr. Charles Stacey is a physician, entrepreneur, and biotech leader committed to transforming brain health. As President and CEO of Cerecin, he leads the development of breakthrough therapeutics for neurological diseases. Before Cerecin, Charles was part of Inventages, a venture capital group managing $1.5B in global health investments. He has founded and led medical technology companies, and began his career as a trauma and reconstructive surgeon after earning his medical degree from King’s College London and a bachelor’s in neuroscience from UCL. He also holds an MBA from both the London Business School and the Wharton School. In addition to his leadership at Cerecin, Charles is an active investor and advisor to early-stage life science companies. Passionate about innovation and driven by human impact, he is focused on innovating for impact—bringing a rare blend of clinical insight, entrepreneurial drive, and visionary thinking to the future of healthcare.
